{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:31:02Z","timestamp":1793640662890,"version":"4.5.1"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260080"],"award-info":[{"award-number":["82260080"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260080"],"award-info":[{"award-number":["82260080"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260080"],"award-info":[{"award-number":["82260080"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260080"],"award-info":[{"award-number":["82260080"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32060206"],"award-info":[{"award-number":["32060206"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008871","name":"Yunnan Province Science and Technology Department","doi-asserted-by":"crossref","award":["202401AY070001-046"],"award-info":[{"award-number":["202401AY070001-046"]}],"id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008871","name":"Yunnan Province Science and Technology Department","doi-asserted-by":"crossref","award":["202401AY070001-046"],"award-info":[{"award-number":["202401AY070001-046"]}],"id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008871","name":"Yunnan Province Science and Technology Department","doi-asserted-by":"crossref","award":["202401AY070001-046"],"award-info":[{"award-number":["202401AY070001-046"]}],"id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008871","name":"Yunnan Province Science and Technology Department","doi-asserted-by":"crossref","award":["202401AY070001-046"],"award-info":[{"award-number":["202401AY070001-046"]}],"id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Yunnan Fundamental Research Projects","award":["20221AS070081"],"award-info":[{"award-number":["20221AS070081"]}]},{"name":"Yunnan Fundamental Research Projects","award":["20221AS070081"],"award-info":[{"award-number":["20221AS070081"]}]},{"name":"Yunnan Fundamental Research Projects","award":["20221AS070081"],"award-info":[{"award-number":["20221AS070081"]}]},{"name":"Yunnan Fundamental Research Projects","award":["20221AS070081"],"award-info":[{"award-number":["20221AS070081"]}]},{"name":"veterinary Public Health Innovation Team of Yunnan Province","award":["202105AE160014"],"award-info":[{"award-number":["202105AE160014"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc. Diabetol. \u2013 Endocrinol. Rep."],"DOI":"10.1186\/s40842-025-00231-x","type":"journal-article","created":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T22:07:14Z","timestamp":1757282834000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The heart of diabetes: unraveling metabolic drivers of cardiomyopathy"],"prefix":"10.1186","volume":"11","author":[{"given":"Xue","family":"Guan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haizhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"key":"231_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109\u201319.","journal-title":"Diabetes Res Clin Pract."},{"issue":"5","key":"231_CR2","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","volume":"27","author":"S Wild","year":"2004","unstructured":"Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047\u201353.","journal-title":"Diabetes Care."},{"issue":"10394","key":"231_CR3","doi-asserted-by":"publisher","first-page":"12149","DOI":"10.1016\/S0140-6736(23)00223-4","volume":"401","author":"T Quattrin","year":"2023","unstructured":"Quattrin T, Mastrandrea LD, Walker LSK. Type 1 diabetes. Lancet. 2023;401(10394):12149\u201362.","journal-title":"Lancet."},{"issue":"3","key":"231_CR4","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1093\/cvr\/cvab120","volume":"118","author":"QG Karwi","year":"2022","unstructured":"Karwi QG, Ho KL, Pherwani S, Ketema EB, Sun Q, Lopaschuk GD. Concurrent diabetes and heart failure: interplay and novel therapeutic approaches. Cardiovasc Res. 2022;118(3):1686\u2013715.","journal-title":"Cardiovasc Res."},{"issue":"9","key":"231_CR5","first-page":"1893","volume":"26","author":"PM Seferovi\u0107","year":"2024","unstructured":"Seferovi\u0107 PM, Paulus WJ, Rosano G, Polovina M, Petrie MC, Jhund PS, et al. Diabetic myocardial disorder. A clinical consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial Pericardial Diseases. Eur J Heart Fail. 2024;26(9):1893\u2013903.","journal-title":"Eur J Heart Fail."},{"issue":"10","key":"231_CR6","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41569-023-00877-z","volume":"20","author":"ND Wong","year":"2023","unstructured":"Wong ND, Sattar N. Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention. Nat Rev Cardiol. 2023;20(10):685\u201395.","journal-title":"Nat Rev Cardiol"},{"key":"231_CR7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","volume":"138","author":"NH Cho","year":"2018","unstructured":"Cho NH, Shaw JE, Karuranga S, Huang Y, Da Rocha Fernandes JD, Ohlrogge AW. Malanda B IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271\u201381.","journal-title":"Diabetes Res Clin Pract."},{"issue":"9","key":"231_CR8","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.amjmed.2008.03.046","volume":"121","author":"A Aneja","year":"2008","unstructured":"Aneja A, Tang WH, Bansilal S, Garcia MJ, Farkouh ME. Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. Am J Med. 2008;121(9):748\u201357.","journal-title":"Am J Med."},{"issue":"3","key":"231_CR9","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1900\/RDS.2006.3.108","volume":"3","author":"J Wang","year":"2006","unstructured":"Wang J, Song Y, Wang Q, Kralik PM, Epstein PN. Causes and characteristics of diabetic cardiomyopathy. Rev Diabet Stud. 2006;3(3):108\u201317.","journal-title":"Rev Diabet Stud."},{"key":"231_CR10","doi-asserted-by":"crossref","unstructured":"Shah AD, Langenberg C, Rapsomaniki E, Denaxas S, Pujades-Rodriguez M, Gale CP, et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1$$\\cdot$$9 million people. Lancet Diabetes Endocrinol. 2015;3(2):105\u201313.","DOI":"10.1016\/S2213-8587(14)70219-0"},{"issue":"33","key":"231_CR11","first-page":"3456","volume":"260","author":"RD Abbott","year":"1988","unstructured":"Abbott RD, Donahue RP, Kannel WB. Wilson PW The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study Jama. 1988;260(33):3456\u201360.","journal-title":"The Framingham Study. Jama."},{"issue":"4","key":"231_CR12","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1172\/JCI108843","volume":"60","author":"TJ Regan","year":"1977","unstructured":"Regan TJ, Lyons MM, Ahmed SS, Levinson GE, Oldewurtel HA, Ahmad MR. Haider B Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest. 1977;60(4):884\u201399.","journal-title":"J Clin Invest."},{"issue":"1","key":"231_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/CIRCULATIONAHA.107.728550","volume":"117","author":"L Van Heerebeek","year":"2008","unstructured":"Van Heerebeek L, Hamdani N, Handoko ML, Falcao-Pires I, Musters RJ, Kupreishvili K, et al. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation. 2008;117(1):43\u201351.","journal-title":"Circulation."},{"issue":"8","key":"231_CR14","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1161\/01.CIR.101.8.899","volume":"101","author":"K Mizushige","year":"2000","unstructured":"Mizushige K, Yao L, Noma T, Kiyomoto H, Yu Y, Hosomi N, et al. Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin- resistant prediabetic stage of a type II diabetic rat model. Circulation. 2000;101(8):899\u2013907.","journal-title":"Circulation."},{"issue":"13","key":"231_CR15","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.4239\/wjd.v6.i13.1246","volume":"6","author":"BM Leon","year":"2015","unstructured":"Leon BM. Maddox TM Diabetes and cardiovascular disease: Epidemiology, biological mech- anisms, treatment recommendations and future research. World J Diabetes. 2015;6(13):1246\u201358.","journal-title":"World J Diabetes."},{"key":"231_CR16","doi-asserted-by":"publisher","unstructured":"Karwi QG, Sun Q, Lopaschuk GD. The Contribution of Cardiac Fatty Acid Oxidation to Diabetic Cardiomyopathy Severity. Cells. 2021;10(11):3259.\u00a0https:\/\/doi.org\/10.3390\/cells10113259. PMID: 34831481; PMCID: PMC8621814.","DOI":"10.3390\/cells10113259"},{"issue":"6","key":"231_CR17","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","volume":"30","author":"S Rubler","year":"1972","unstructured":"Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW. Grishman A New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 1972;30(6):595\u2013602.","journal-title":"Am J Cardiol."},{"issue":"5","key":"231_CR18","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2337\/dbi23-0019","volume":"73","author":"LC Heather","year":"2024","unstructured":"Heather LC, Gopal K, Srnic N. Ussher JR Redefining Diabetic Cardiomyopathy: Perturbations in Substrate Metabolism at the Heart of Its Pathology. Diabetes. 2024;73(5):659\u201370.","journal-title":"Diabetes."},{"issue":"5","key":"231_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4239\/wjd.v4.i5.177","volume":"4","author":"JM Pappachan","year":"2013","unstructured":"Pappachan JM, Varughese GI, Sriraman R. Arunagirinathan G Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management. World J Diabetes. 2013;4(5):177\u201389.","journal-title":"World J Diabetes."},{"issue":"3","key":"231_CR20","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.hfc.2019.02.003","volume":"15","author":"S Paolillo","year":"2019","unstructured":"Paolillo S, Marsico F, Prastaro M, Renga F, Esposito L, De Martino F, et al. Diabetic Cardiomyopathy: Definition, Diagnosis, and Therapeutic Implications. Heart Fail Clin. 2019;15(3):341\u20137.","journal-title":"Heart Fail Clin."},{"issue":"1","key":"231_CR21","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/s41420-023-01553-4","volume":"9","author":"JL Huo","year":"2023","unstructured":"Huo JL, Feng Q, Pan S, Fu WJ, Liu Z, Liu Z. Diabetic cardiomyopathy: Early diagnostic biomarkers, pathogenetic mechanisms, and therapeutic interventions. Cell Death Discov. 2023;9(1):256.","journal-title":"Cell Death Discov."},{"key":"231_CR22","doi-asserted-by":"publisher","unstructured":"Fabila-De\u00a0La\u00a0Cruz OD, Luna-Avila ES, Sotelo-Gonz\u00e1lez MDP, Litardo-Mosquera AD, Orihuela O, Ferreira-Hermosillo A. Prevalence of Cardiomyopathy in Patients with Type 1 Diabetes Mellitus. J Clin Med. 2024;13(8):5351. https:\/\/doi.org\/10.3390\/jcm13185351. PMID: 39336838; PMCID: PMC11432088.","DOI":"10.3390\/jcm13185351"},{"issue":"3","key":"231_CR23","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.yjmcc.2009.06.021","volume":"48","author":"L Maya","year":"2010","unstructured":"Maya L, Villarreal FJ. Diagnostic approaches for diabetic cardiomyopathy and myocardial fibrosis. J Mol Cell Cardiol. 2010;48(3):524\u20139.","journal-title":"J Mol Cell Cardiol."},{"issue":"3","key":"231_CR24","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2143\/AC.64.3.2038017","volume":"64","author":"W Dinh","year":"2009","unstructured":"Dinh W, Bansemir L, Fu\u1e97h R, Nickl W, Stasch JP, Coll-Barroso M, et al. Increased levels of laminin and collagen type VI may reflect early remodelling in patients with acute myocardial infarction. Acta Cardiol. 2009;64(3):329\u201334.","journal-title":"Acta Cardiol."},{"issue":"9","key":"231_CR25","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1113\/expphysiol.2011.058271","volume":"96","author":"A D\u2019souza","year":"2011","unstructured":"D\u2019souza A, Howarth FC, Yanni J, Dobryznski H, Boyett MR, Adeghate E, et al. Left ventricle structural remodelling in the prediabetic Goto-Kakizaki rat. Exp Physiol. 2011;96(9):875\u201388.","journal-title":"Exp Physiol."},{"issue":"3","key":"231_CR26","first-page":"575","volume":"4","author":"CR Ban","year":"2008","unstructured":"Ban CR, Twigg SM. Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers. Vasc Health Risk Manag. 2008;4(3):575\u201396.","journal-title":"Vasc Health Risk Manag."},{"issue":"11","key":"231_CR27","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/sj.ijo.0803022","volume":"29","author":"D Quilliot","year":"2005","unstructured":"Quilliot D, Alla F, B\u00f6hme P, Bruntz JF, Hammadi M, Dousset B, et al. Myocardial collagen turnover in normotensive obese patients: relation to insulin resistance. Int J Obes (Lond). 2005;29(11):1321\u20138.","journal-title":"Int J Obes (Lond)."},{"issue":"11","key":"231_CR28","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.2337\/dc09-0552","volume":"32","author":"NE Russell","year":"2009","unstructured":"Russell NE, Higgins MF, Amaruso M, Foley M, Mcauliffe FM. Troponin T and pro-B-type natriuretic Peptide in fetuses of type 1 diabetic mothers. Diabetes Care. 2009;32(11):2050\u20135.","journal-title":"Diabetes Care."},{"issue":"7","key":"231_CR29","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.2337\/diacare.26.7.2081","volume":"26","author":"V Epshteyn","year":"2003","unstructured":"Epshteyn V, Morrison K, Krishnaswamy P, Kazanegra R, Clopton P, Mudaliar S, et al. Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes. Diabetes Care. 2003;26(7):2081\u20137.","journal-title":"Diabetes Care."},{"key":"231_CR30","first-page":"151","volume":"6","author":"V Chavali","year":"2013","unstructured":"Chavali V, Tyagi SC, Mishra PK. Predictors and prevention of diabetic cardiomyopathy. Diabetes Metab Syndr Obes. 2013;6:151\u201360.","journal-title":"Diabetes Metab Syndr Obes."},{"issue":"10","key":"231_CR31","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1161\/CIRCULATIONAHA.106.645614","volume":"116","author":"JM Mcgavock","year":"2007","unstructured":"Mcgavock JM, Lingvay I, Zib I, Tillery T, Salas N, Unger R, et al. Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation. 2007;116(10):1170\u20135.","journal-title":"Circulation."},{"issue":"9","key":"231_CR32","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","volume":"17","author":"Y Tan","year":"2020","unstructured":"Tan Y, Zhang Z, Zheng C, Wintergerst KA, Keller BB, Cai L. Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence. Nat Rev Cardiol. 2020;17(9):585\u2013607.","journal-title":"Nat Rev Cardiol."},{"key":"231_CR33","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1016\/j.biopha.2018.11.086","volume":"109","author":"AM Al Hroob","year":"2019","unstructured":"Al Hroob AM, Abukhalil MH, Hussein OE. Mahmoud AM Pathophysiological mechanisms of diabetic cardiomyopathy and the therapeutic potential of epigallocatechin-3-gallate. Biomed Pharmacother. 2019;109:2155\u201372.","journal-title":"Biomed Pharmacother."},{"key":"231_CR34","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.3389\/fphys.2018.01514","volume":"9","author":"G Borghetti","year":"2018","unstructured":"Borghetti G, Von Lewinski D, Eaton DM, Sourij H. Diabetic Car- diomyopathy: Current and Future Therapies. Beyond Glycemic Control. Front Physiol. 2018;9:1514.","journal-title":"Front Physiol."},{"key":"231_CR35","doi-asserted-by":"publisher","first-page":"750382","DOI":"10.3389\/fcell.2021.750382","volume":"9","author":"H Zheng","year":"2021","unstructured":"Zheng H, Zhu H, Liu X, Huang X, Huang A, Huang Y. Mitophagy in Diabetic Cardiomyopathy: Roles and Mechanisms. Front Cell Dev Biol. 2021;9:750382.","journal-title":"Front Cell Dev Biol."},{"issue":"10","key":"231_CR36","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1042\/CS20080500","volume":"116","author":"O Asghar","year":"2009","unstructured":"Asghar O, Al-Sunni A, Khavandi K, Khavandi A, Withers S, Greenstein A, et al. Diabetic cardiomyopathy. Clin Sci (Lond). 2009;116(10):741\u201360.","journal-title":"Clin Sci (Lond)."},{"key":"231_CR37","doi-asserted-by":"publisher","first-page":"570421","DOI":"10.3389\/fphys.2020.570421","volume":"11","author":"AA Greenwell","year":"2020","unstructured":"Greenwell AA, Gopal K, Ussher JR. Myocardial Energy Metabolism in Non-ischemic Car- diomyopathy. Front Physiol. 2020;11:570421.","journal-title":"Front Physiol."},{"issue":"3","key":"231_CR38","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.bbrc.2016.11.088","volume":"482","author":"H Vakifahmetoglu-Norberg","year":"2017","unstructured":"Vakifahmetoglu-Norberg H, Ouchida AT, Norberg E. The role of mitochondria in metabolism and cell death. Biochem Biophys Res Commun. 2017;482(3):426\u201331.","journal-title":"Biochem Biophys Res Commun."},{"issue":"4","key":"231_CR39","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1152\/physrev.00058.2021","volume":"103","author":"JS Harrington","year":"2023","unstructured":"Harrington JS, Ryter SW, Plataki M, Price DR, Choi AMK. Mitochondria in health, disease, and aging. Physiol Rev. 2023;103(4):2349\u2013422.","journal-title":"Physiol Rev."},{"issue":"9","key":"231_CR40","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/1873-3468.14298","volume":"596","author":"D Trigo","year":"2022","unstructured":"Trigo D, Avelar C, Fernandes M, S\u00e1 J, Da Cruz ESO. Mitochondria, energy, and metabolism in neuronal health and disease. FEBS Lett. 2022;596(9):1095\u2013110.","journal-title":"FEBS Lett."},{"key":"231_CR41","doi-asserted-by":"publisher","first-page":"1114231","DOI":"10.3389\/fphys.2023.1114231","volume":"14","author":"A Casanova","year":"2023","unstructured":"Casanova A, Wevers A, Navarro-Ledesma S, Pruimboom L. Mitochondria: It is all about energy. Front Physiol. 2023;14:1114231.","journal-title":"Front Physiol."},{"issue":"6\u20137","key":"231_CR42","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.bbabio.2010.01.004","volume":"1797","author":"I Bratic","year":"2010","unstructured":"Bratic I, Trifunovic A. Mitochondrial energy metabolism and ageing. Biochim Biophys Acta. 2010;1797(6\u20137):961\u20137.","journal-title":"Biochim Biophys Acta."},{"issue":"1","key":"231_CR43","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13287-021-02194-z","volume":"12","author":"W Yan","year":"2021","unstructured":"Yan W, Diao S, Fan Z. The role and mechanism of mitochondrial functions and energy metabolism in the function regulation of the mesenchymal stem cells. Stem Cell Res Ther. 2021;12(1):140.","journal-title":"Stem Cell Res Ther."},{"key":"231_CR44","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.coph.2020.08.015","volume":"54","author":"S Nirengi","year":"2020","unstructured":"Nirengi S, Peres\u00a0Valgas\u00a0Da\u00a0Silva C, Stanford KI. Disruption of energy utilization in diabetic cardiomyopathy; a mini review. Curr Opin Pharmacol. 2020;54:82\u201390.","journal-title":"Curr Opin Pharmacol."},{"issue":"4","key":"231_CR45","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia G, Hill MA, Sowers JR. Diabetic Cardiomyopathy: An Update of Mech- anisms Contributing to This Clinical Entity. Circ Res. 2018;122(4):624\u201338.","journal-title":"Circ Res."},{"issue":"6","key":"231_CR46","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s12192-023-01361-w","volume":"28","author":"F Zhi","year":"2023","unstructured":"Zhi F, Zhang Q, Liu L, Chang X, Xu H. Novel insights into the role of mitochondria in diabetic cardiomyopathy: molecular mechanisms and potential treatments. Cell Stress Chaperones. 2023;28(6):641\u201355.","journal-title":"Cell Stress Chaperones."},{"key":"231_CR47","doi-asserted-by":"publisher","unstructured":"Correia M, Santos F, da Silva Ferreira R, Ferreira R, Bernardes de Jesus B, N\u00f3brega-Pereira S. Metabolic Determinants in Cardiomyocyte Function and Heart Regenerative Strategies. Metabolites. 2022;12(6):500. https:\/\/doi.org\/10.3390\/metabo12060500. PMID: 35736435; PMCID: PMC9227827.","DOI":"10.3390\/metabo12060500"},{"issue":"4","key":"231_CR48","doi-asserted-by":"publisher","first-page":"H1489","DOI":"10.1152\/ajpheart.00278.2006","volume":"291","author":"D An","year":"2006","unstructured":"An D, Rodrigues B. Role of changes in cardiac metabolism in development of di- abetic cardiomyopathy. Am J Physiol Heart Circ Physiol. 2006;291(4):H1489-506.","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"231_CR49","doi-asserted-by":"publisher","unstructured":"Wang X, Shen X, Yan Y, Li H. Pyruvate dehydrogenase kinases (PDKs): an overview toward clinical applications. Biosci Rep. 2021;41(4):BSR20204402. https:\/\/doi.org\/10.1042\/BSR20204402. PMID: 33739396; PMCID: PMC8026821.","DOI":"10.1042\/BSR20204402"},{"issue":"11","key":"231_CR50","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1074\/jbc.M116.753509","volume":"292","author":"SS Vadvalkar","year":"2017","unstructured":"Vadvalkar SS, Matsuzaki S, Eyster CA, Giorgione JR, Bockus LB, Kinter CS, et al. Decreased Mitochondrial Pyruvate Transport Activity in the Diabetic Heart: ROLE OF MITOCHONDRIAL PYRUVATE CARRIER 2 (MPC2) ACETYLATION. J Biol Chem. 2017;292(11):4423\u201333.","journal-title":"J Biol Chem."},{"issue":"2","key":"231_CR51","doi-asserted-by":"publisher","first-page":"E331","DOI":"10.1152\/ajpendo.00298.2002","volume":"284","author":"AS Augustus","year":"2003","unstructured":"Augustus AS, Kako Y, Yagyu H, Goldberg IJ. Routes of FA delivery to cardiac muscle: modulation of lipoprotein lipolysis alters uptake of TG-derived FA. Am J Physiol Endocrinol Metab. 2003;284(2):E331-9.","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"231_CR52","doi-asserted-by":"publisher","first-page":"948332","DOI":"10.3389\/fcvm.2022.948332","volume":"9","author":"V Cifarelli","year":"2022","unstructured":"Cifarelli V, Kuda O, Yang K, Liu X, Gross RW, Pietka TA, et al. Cardiac immune cell infiltration associates with abnormal lipid metabolism. Front Cardiovasc Med. 2022;9:948332.","journal-title":"Front Cardiovasc Med."},{"issue":"7","key":"231_CR53","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1194\/jlr.R082933","volume":"59","author":"JFC Glatz","year":"2018","unstructured":"Glatz JFC. Luiken J Dynamic role of the transmembrane glycoprotein CD36 (SR- B2) in cellular fatty acid uptake and utilization. J Lipid Res. 2018;59(7):1084\u201393.","journal-title":"J Lipid Res."},{"issue":"6","key":"231_CR54","doi-asserted-by":"publisher","first-page":"e000433","DOI":"10.1161\/JAHA.113.000433","volume":"2","author":"M Bayeva","year":"2013","unstructured":"Bayeva M, Sawicki KT, Ardehali H. Taking diabetes to heart\u2013deregulation of myocardial lipid metabolism in diabetic cardiomyopathy. J Am Heart Assoc. 2013;2(6):e000433.","journal-title":"J Am Heart Assoc."},{"issue":"1","key":"231_CR55","doi-asserted-by":"publisher","first-page":"10","DOI":"10.31083\/j.fbl2801010","volume":"28","author":"Q He","year":"2023","unstructured":"He Q, Chen Y, Wang Z, He H, Yu P. Cellular Uptake, Metabolism and Sens- ing of Long-Chain Fatty Acids. Front Biosci (Landmark Ed). 2023;28(1):10.","journal-title":"Front Biosci (Landmark Ed)."},{"issue":"2","key":"231_CR56","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1006\/bbrc.2001.5608","volume":"287","author":"P Wu","year":"2001","unstructured":"Wu P, Peters JM, Harris RA. Adaptive increase in pyruvate dehydrogenase kinase 4 during starvation is mediated by peroxisome proliferator-activated receptor alpha. Biochem Biophys Res Commun. 2001;287(2):391\u20136.","journal-title":"Biochem Biophys Res Commun."},{"issue":"20","key":"231_CR57","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/j.jacc.2009.07.031","volume":"54","author":"EJ Anderson","year":"2009","unstructured":"Anderson EJ, Kypson AP, Rodriguez E, Anderson CA, Lehr EJ, Neufer PD. Substrate- specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart. J Am Coll Cardiol. 2009;54(20):1891\u20138.","journal-title":"J Am Coll Cardiol."},{"issue":"16","key":"231_CR58","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.jacc.2009.04.074","volume":"54","author":"LJ Rijzewijk","year":"2009","unstructured":"Rijzewijk LJ, Van Der Meer RW, Lamb HJ, De Jong HW, Lubberink M, Romijn JA, et al. Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging. Am Coll Cardiol. 2009;54(16):1524\u201332.","journal-title":"Am Coll Cardiol."},{"issue":"3","key":"231_CR59","doi-asserted-by":"publisher","first-page":"826","DOI":"10.14336\/AD.2020.1217","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang X, Fan J, Li H, Chen C, Wang Y. CD36 Signaling in Diabetic Cardiomyopathy. Aging Dis. 2021;12(3):826\u201340.","journal-title":"Aging Dis."},{"issue":"12","key":"231_CR60","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1161\/CIRCRESAHA.119.314898","volume":"125","author":"H Li","year":"2019","unstructured":"Li H, Fan J, Zhao Y, Zhang X, Dai B, Zhan J, et al. Nuclear miR-320 Mediates Diabetes-Induced Cardiac Dysfunction by Activating Transcription of Fatty Acid Metabolic Genes to Cause Lipotoxicity in the Heart. Circ Res. 2019;125(12):1106\u201320.","journal-title":"Circ Res."},{"issue":"1","key":"231_CR61","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/cvr\/cvaa319","volume":"118","author":"H Shu","year":"2022","unstructured":"Shu H, Peng Y, Hang W, Nie J, Zhou N, Wang DW. The role of CD36 in cardiovascular disease. Cardiovasc Res. 2022;118(1):115\u201329.","journal-title":"Cardiovasc Res."},{"issue":"10","key":"231_CR62","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.2337\/diabetes.51.10.3113","volume":"51","author":"JJ Luiken","year":"2002","unstructured":"Luiken JJ, Koonen DP, Willems J, Zorzano A, Becker C, Fischer Y, et al. Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT\/CD36. Diabetes. 2002;51(10):3113\u20139.","journal-title":"Diabetes."},{"key":"231_CR63","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ijcard.2017.07.096","volume":"245","author":"DA Chistiakov","year":"2017","unstructured":"Chistiakov DA, Orekhov AN, Bobryshev YV. The impact of FOXO-1 to cardiac pathology in diabetes mellitus and diabetes-related metabolic abnormalities. Int J Cardiol. 2017;245:236\u201344.","journal-title":"Int J Cardiol."},{"key":"231_CR64","doi-asserted-by":"publisher","unstructured":"Han B, Wang J, Wu J, Yan F, Wang Y, Li J. High glucose\u2011induced upregulation of CD36 promotes inflammation stress via NF\u2011\u03baB in H9c2 cells. Mol Med Rep. 2021;24(5):764. https:\/\/doi.org\/10.3892\/mmr.2021.12404. Epub 2021 Sep 7. PMID: 34490487; PMCID: PMC8430300.","DOI":"10.3892\/mmr.2021.12404"},{"key":"231_CR65","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.omtn.2023.03.019","volume":"32","author":"E Kankuri","year":"2023","unstructured":"Kankuri E. Positive feedback loop of miR-320 and CD36 regulates the hyperglycemic memory- induced diabetic diastolic cardiac dysfunction. Mol Ther Nucleic Acids. 2023;32:318\u201321.","journal-title":"Mol Ther Nucleic Acids."},{"issue":"25","key":"231_CR66","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1161\/CIRCULATIONAHA.106.679597","volume":"115","author":"S Boudina","year":"2007","unstructured":"Boudina S. Abel ED Diabetic cardiomyopathy revisited. Circulation. 2007;115(25):3213\u201323.","journal-title":"Circulation."},{"issue":"1","key":"231_CR67","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/cvr\/cvr212","volume":"92","author":"T Van De Weijer","year":"2011","unstructured":"Van De Weijer T, Schrauwen-Hinderling VB, Schrauwen P. Lipotoxicity in type 2 diabetic cardiomyopathy. Cardiovasc Res. 2011;92(1):10\u20138.","journal-title":"Cardiovasc Res."},{"issue":"6","key":"231_CR68","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/s42255-024-01036-5","volume":"6","author":"H Wang","year":"2024","unstructured":"Wang H, Wang J, Cui H, Fan C, Xue Y, Liu H, et al. Inhibition of fatty acid uptake by TGR5 prevents diabetic cardiomyopathy. Nat Metab. 2024;6(6):1161\u201377.","journal-title":"Nat Metab."},{"issue":"6","key":"231_CR69","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S1050-1738(00)00077-3","volume":"10","author":"PM Barger","year":"2000","unstructured":"Barger PM, Kelly DP. PPAR signaling in the control of cardiac energy metabolism. Trends Cardiovasc Med. 2000;10(6):238\u201345.","journal-title":"Trends Cardiovasc Med."},{"issue":"6","key":"231_CR70","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.1074\/jbc.M106054200","volume":"277","author":"FM Campbell","year":"2002","unstructured":"Campbell FM, Kozak R, Wagner A, Altarejos JY, Dyck JR, Belke DD, et al. A role for peroxisome proliferator-activated receptor alpha (PPARalpha ) in the control of cardiac malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARalpha are associated with higher concentrations of malonyl-CoA and reduced expression of malonyl-CoA decarboxylase. J Biol Chem. 2002;277(6):4098\u2013103.","journal-title":"J Biol Chem."},{"key":"231_CR71","doi-asserted-by":"crossref","unstructured":"Oka S, Alcendor R, Zhai P, Park JY, Shao D, Cho J, et al. PPAR\u03b1-Sirt1 complex mediates cardiac hypertrophy and failure through suppression of the ERR transcriptional pathway. Cell Metab. 2011;14(5):598\u2013611.","DOI":"10.1016\/j.cmet.2011.10.001"},{"key":"231_CR72","doi-asserted-by":"crossref","unstructured":"Rostami A, Palomer X, Pizarro-Delgado J, Barroso E, Valenzuela-Alcaraz B, Crispi F, et al. PPAR\u03b2\/\u03b4 prevents inflam- mation and fibrosis during diabetic cardiomyopathy. Pharmacol Res. 2024;210:107515.","DOI":"10.1016\/j.phrs.2024.107515"},{"issue":"4","key":"231_CR73","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1016\/j.ijcard.2013.07.150","volume":"168","author":"X Palomer","year":"2013","unstructured":"Palomer X, Salvad\u00f3 L, Barroso E, V\u00e1zquez-Carrera M. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy. Int J Cardiol. 2013;168(4):3160\u201372.","journal-title":"Int J Cardiol."},{"issue":"5","key":"231_CR74","doi-asserted-by":"publisher","first-page":"E1104","DOI":"10.1152\/ajpendo.2000.279.5.E1104","volume":"279","author":"DD Belke","year":"2000","unstructured":"Belke DD, Larsen TS, Gibbs EM, Severson DL. Altered metabolism causes cardiac dysfunc- tion in perfused hearts from diabetic (db\/db) mice. Am J Physiol Endocrinol Metab. 2000;279(5):E1104-13.","journal-title":"Am J Physiol Endocrinol Metab."},{"issue":"2","key":"231_CR75","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1161\/01.RES.65.2.378","volume":"65","author":"GD Lopaschuk","year":"1989","unstructured":"Lopaschuk GD. Spafford M Response of isolated working hearts to fatty acids and carnitine palmitoyltransferase I inhibition during reduction of coronary flow in acutely and chronically diabetic rats. Circ Res. 1989;65(2):378\u201387.","journal-title":"Circ Res."},{"key":"231_CR76","doi-asserted-by":"crossref","unstructured":"Yan M, Su L, Wu K, Mei Y, Liu Z, Chen Y, et al. USP7 promotes cardiometabolic disorders and mitochondrial homeostasis dys- function in diabetic mice via stabilizing PGC1$$\\beta$$. Pharmacol Res. 2024;205:107235.","DOI":"10.1016\/j.phrs.2024.107235"},{"issue":"1","key":"231_CR77","doi-asserted-by":"publisher","first-page":"20535","DOI":"10.1038\/s41598-022-24736-y","volume":"12","author":"AM Koester","year":"2022","unstructured":"Koester AM, Geiser A, Bowman PRT, Van De Linde S, Gadegaard N, Bryant NJ, Gould GW. GLUT4 translocation and dispersal operate in multiple cell types and are negatively correlated with cell size in adipocytes. Sci Rep. 2022;12(1):20535.","journal-title":"Sci Rep."},{"key":"231_CR78","doi-asserted-by":"publisher","unstructured":"Zimmermann P, Schierbauer J, Kopf N, Sourij H, Oliver N, Aberer F, Wachsmuth NB, Moser O. Speckle-Tracking Analysis of the Right and Left Heart after Peak Exercise in Healthy Subjects with Type 1 Diabetes: An Explorative Analysis of the AppEx Trial. J Cardiovasc Dev Dis. 2023;10(11):467. https:\/\/doi.org\/10.3390\/jcdd10110467. PMID: 37998525; PMCID: PMC10672090.","DOI":"10.3390\/jcdd10110467"},{"issue":"2","key":"231_CR79","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1124\/jpet.123.002037","volume":"391","author":"HM Hashiesh","year":"2024","unstructured":"Hashiesh HM, Azimullah S, Nagoor Meeran MF, Saraswathiamma D, Arunachalam S, Jha NK, et al. Cannabinoid 2 Receptor Activation Protects against Diabetic Cardiomyopathy through Inhibition of AGE\/RAGE-Induced Oxidative Stress, Fibrosis, and Inflammasome Activation. J Pharmacol Exp Ther. 2024;391(2):241\u201357.","journal-title":"J Pharmacol Exp Ther."},{"issue":"1","key":"231_CR80","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12916-023-02887-7","volume":"21","author":"X Zhang","year":"2023","unstructured":"Zhang X, Duan Y, Zhang X, Jiang M, Man W, Zhang Y, et al. Adipsin alleviates cardiac microvascular injury in diabetic cardiomyopathy through Csk-dependent signaling mechanism. BMC Med. 2023;21(1):197.","journal-title":"BMC Med."},{"key":"231_CR81","doi-asserted-by":"crossref","unstructured":"Uphues I, Kolter T, Goud B, Eckel J. Failure of insulin-regulated recruitment of the glucose transporter GLUT4 in cardiac muscle of obese Zucker rats is associated with alterations of small- molecular-mass GTP-binding proteins. Biochem J. 1995;311(Pt 1):161\u20136.","DOI":"10.1042\/bj3110161"},{"issue":"3","key":"231_CR82","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1042\/BST20221066","volume":"51","author":"J Van Gerwen","year":"2023","unstructured":"Van Gerwen J, Shun-Shion AS, Fazakerley DJ. Insulin signalling and GLUT4 trafficking in insulin resistance. Biochem Soc Trans. 2023;51(3):1057\u201369.","journal-title":"Biochem Soc Trans."},{"issue":"1","key":"231_CR83","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12929-016-0309-5","volume":"24","author":"TW Lee","year":"2017","unstructured":"Lee TW, Bai KJ, Lee TI, Chao TF, Kao YH, Chen YJ. PPARs modulate cardiac metabolism and mitochondrial function in diabetes. J Biomed Sci. 2017;24(1):5.","journal-title":"J Biomed Sci."},{"issue":"5","key":"231_CR84","doi-asserted-by":"publisher","first-page":"e018913","DOI":"10.1161\/JAHA.120.018913","volume":"10","author":"L Li","year":"2021","unstructured":"Li L, Zeng H, He X, Chen JX. Sirtuin 3 Alleviates Diabetic Cardiomyopathy by Regu- lating TIGAR and Cardiomyocyte Metabolism. J Am Heart Assoc. 2021;10(5):e018913.","journal-title":"J Am Heart Assoc."},{"key":"231_CR85","doi-asserted-by":"publisher","first-page":"1375400","DOI":"10.3389\/fcvm.2024.1375400","volume":"11","author":"Y Zeng","year":"2024","unstructured":"Zeng Y, Li Y, Jiang W, Hou N. Molecular mechanisms of metabolic dysreg- ulation in diabetic cardiomyopathy. Front Cardiovasc Med. 2024;11:1375400.","journal-title":"Front Cardiovasc Med."},{"key":"231_CR86","doi-asserted-by":"publisher","unstructured":"Bagul PK, Katare PB, Bugga P, Dinda AK, Banerjee SK. SIRT-3 Modulation by Resveratrol Improves Mitochondrial Oxidative Phosphorylation in Diabetic Heart through Deacetylation of TFAM. Cells. 2018;7(12). https:\/\/doi.org\/10.3390\/cells7120235. PMID: 30487434; PMCID: PMC6315986.","DOI":"10.3390\/cells7120235"},{"issue":"8","key":"231_CR87","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1089\/ars.2017.7178","volume":"28","author":"N D\u2019onofrio","year":"2018","unstructured":"D\u2019onofrio N, Servillo L, Balestrieri ML. SIRT1 and SIRT6 Signaling Pathways in Cardiovascular Disease Protection. Antioxid Redox Signal. 2018;28(8):711\u201332.","journal-title":"Antioxid Redox Signal."},{"key":"231_CR88","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.biopha.2017.03.056","volume":"90","author":"H Karbasforooshan","year":"2017","unstructured":"Karbasforooshan H, Karimi G. The role of SIRT1 in diabetic cardiomyopathy. Biomed Pharmacother. 2017;90:386\u201392.","journal-title":"Biomed Pharmacother."},{"key":"231_CR89","doi-asserted-by":"publisher","unstructured":"Liu Y, Yu J, Hu H, Pu S, Wu H, Ma Y, Yang W, Fang C, Sun F, Wang H. Multi-omics analysis reveals metabolic disruptions in cardiac tissues of aging nonhuman primates with spontaneous type 2 diabetes. Aging (Albany NY). 2025;17(6):1386-1404. https:\/\/doi.org\/10.18632\/aging.206261. Epub 2025 Jun 2. PMID: 40464660; PMCID: PMC12245199.","DOI":"10.18632\/aging.206261"},{"issue":"6613","key":"231_CR90","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1126\/science.abn0910","volume":"377","author":"Y Cao","year":"2022","unstructured":"Cao Y, Wang Y, Zhou Z, Pan C, Jiang L, Zhou Z, et al. Liver-heart cross-talk mediated by coagulation factor XI protects against heart failure. Science. 2022;377(6613):1399\u2013406.","journal-title":"Science."},{"issue":"16","key":"231_CR91","doi-asserted-by":"publisher","first-page":"4552","DOI":"10.7150\/thno.24723","volume":"8","author":"TT Tang","year":"2018","unstructured":"Tang TT, Li YY, Li JJ, Wang K, Han Y, Dong WY, et al. Liver-heart crosstalk controls IL-22 activity in cardiac protection after myocardial infarction. Theranostics. 2018;8(16):4552\u201362.","journal-title":"Theranostics."},{"issue":"24","key":"231_CR92","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1097\/CM9.0000000000001890","volume":"134","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Liu D, Long XX, Fang QC, Jia WP, Li HT. The role of FGF21 in the pathogenesis of cardiovascular disease. Chin Med J (Engl). 2021;134(24):2931\u201343.","journal-title":"Chin Med J (Engl)."},{"key":"231_CR93","doi-asserted-by":"publisher","first-page":"205031212093380","DOI":"10.1177\/2050312120933804","volume":"8","author":"G Bisaccia","year":"2019","unstructured":"Bisaccia G, Ricci F, Mantini C, Tana C, Romani GL, Schiavone C, Gallina S. Nonalcoholic fatty liver disease and cardiovascular disease phenotypes. SAGE Open Med. 2019;8:2050312120933804.","journal-title":"SAGE Open Med."},{"issue":"11","key":"231_CR94","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.lfs.2012.10.028","volume":"92","author":"CH Mandavia","year":"2013","unstructured":"Mandavia CH, Aroor AR, Demarco VG, Sowers JR. Molecular and metabolic mechanisms of cardiac dysfunction in diabetes. Life Sci. 2013;92(11):601\u20138.","journal-title":"Life Sci."},{"key":"231_CR95","doi-asserted-by":"crossref","unstructured":"Rostami A, Palomer X, Pizarro-Delgado J, Barroso E, Valenzuela-Alcaraz B, Crispi F, et al. PPAR\u03b2\/\u03b4 prevents inflammation and fibrosis during diabetic cardiomyopathy. Pharmacol Res. 2024;210:107515.","DOI":"10.1016\/j.phrs.2024.107515"},{"issue":"1","key":"231_CR96","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12933-025-02780-y","volume":"24","author":"Z Arnold","year":"2025","unstructured":"Arnold Z, Dostal C, Szab\u00f3 PL, Aykac I, Goncalves AIA, Sousa SL, et al. Tenascin-C drives cardiovascular dysfunction in a mouse model of diabetic cardiomyopathy. Cardiovasc Diabetol. 2025;24(1):235.","journal-title":"Cardiovasc Diabetol."},{"key":"231_CR97","doi-asserted-by":"publisher","first-page":"154910","DOI":"10.1016\/j.metabol.2021.154910","volume":"125","author":"SS Jankauskas","year":"2021","unstructured":"Jankauskas SS, Kansakar U, Varzideh F, Wilson S, Mone P, Lombardi A, et al. Heart failure in diabetes. Metabolism. 2021;125:154910.","journal-title":"Metabolism."},{"issue":"1","key":"231_CR98","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12916-024-03401-3","volume":"22","author":"I Swiatkiewicz","year":"2024","unstructured":"Swiatkiewicz I, Patel NT, Villarreal-Gonzalez M, Taub PR. Prevalence of diabetic cardiomyopathy in patients with type 2 diabetes in a large academic medical center. BMC Med. 2024;22(1):195.","journal-title":"BMC Med."},{"issue":"4","key":"231_CR99","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1161\/CIRCULATIONAHA.122.062769","volume":"147","author":"KA Connelly","year":"2023","unstructured":"Connelly KA, Mazer CD, Puar P, Teoh H, Wang CH, Mason T, et al. Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial. Circulation. 2023;147(4):284\u201395.","journal-title":"Circulation."},{"issue":"20","key":"231_CR100","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/j.jacc.2021.08.068","volume":"78","author":"BP Davidson","year":"2021","unstructured":"Davidson BP, Hodovan J, Layoun ME, Golwala H, Zahr F, Lindner JR. Echocardiographic Ischemic Memory Molecular Imaging for Point-of-Care Detection of Myocardial Ischemia. J Am Coll Cardiol. 2021;78(20):1990\u20132000.","journal-title":"J Am Coll Cardiol."},{"key":"231_CR101","doi-asserted-by":"crossref","unstructured":"Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi, B\u00f6hm M, et al. Empagliflozin in Heart Failure with a Preserved Ejection Fraction. N Engl J Med. 2021;385(16):1451\u201361.","DOI":"10.1056\/NEJMoa2107038"},{"issue":"21","key":"231_CR102","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJV Mcmurray","year":"2019","unstructured":"Mcmurray JJV, Solomon SD, Inzucchi SE, K\u00f8ber L, Kosiborod MN, Martinez FA, et al. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2019;381(21):1995\u20132008.","journal-title":"N Engl J Med."},{"issue":"16","key":"231_CR103","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1016\/j.febslet.2010.07.027","volume":"584","author":"ZX Shan","year":"2010","unstructured":"Shan ZX, Lin QX, Deng CY, Zhu JN, Mai LP, Liu JL, et al. miR-1\/miR-206 regulate Hsp60 expression contributing to glucose-mediated apoptosis in cardiomyocytes. FEBS Lett. 2010;584(16):3592\u2013600.","journal-title":"FEBS Lett."},{"key":"231_CR104","doi-asserted-by":"publisher","unstructured":"Tang Q, Len Q, Liu Z, Wang W. Overexpression of miR-22 attenuates oxidative stress injury in diabetic cardiomyopathy via Sirt 1. Cardiovasc Ther. 2018;36(2): e12318. https:\/\/doi.org\/10.1111\/1755-5922.12318. Epub 2018 Feb 14. PMID: 29288528. Review.","DOI":"10.1111\/1755-5922.12318"},{"issue":"5","key":"231_CR105","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1139\/bcb-2019-0434","volume":"98","author":"J Liu","year":"2020","unstructured":"Liu J, Xu L, Zhan X. LncRNA MALAT1 regulates diabetic cardiac fibroblasts through the Hippo-YAP signaling pathway. Biochem Cell Biol. 2020;98(5):537\u201347.","journal-title":"Biochem Cell Biol."},{"key":"231_CR106","doi-asserted-by":"publisher","first-page":"142191","DOI":"10.1016\/j.scitotenv.2020.142191","volume":"766","author":"C Wang","year":"2021","unstructured":"Wang C, Liu G, Yang H, Guo S, Wang H, Dong Z, et al. MALAT1-mediated recruitment of the histone methyltransferase EZH2 to the microRNA-22 promoter leads to cardiomyocyte apoptosis in diabetic cardiomyopathy. Sci Total Environ. 2021;766:142191.","journal-title":"Sci Total Environ."},{"key":"231_CR107","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ijcard.2015.10.136","volume":"203","author":"M Zhang","year":"2016","unstructured":"Zhang M, Gu H, Xu W, Zhou X. Down-regulation of lncRNA MALAT1 reduces cardiomyocyte apoptosis and improves left ventricular function in diabetic rats. Int J Cardiol. 2016;203:214\u20136.","journal-title":"Int J Cardiol."},{"key":"231_CR108","doi-asserted-by":"crossref","unstructured":"Che H, Wang Y, Li H, Li Y, Sahil A, Lv J, et al. Melatonin alleviates cardiac fibrosis via inhibiting lncRNA MALAT1\/miR-141-mediated NLRP3 inflammasome and TGF-$$\\beta$$1\/Smads signaling in diabetic cardiomyopathy. Faseb j. 2020;34(4):5282\u201398.","DOI":"10.1096\/fj.201902692R"},{"issue":"15","key":"231_CR109","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.7150\/thno.31052","volume":"9","author":"Y Feng","year":"2019","unstructured":"Feng Y, Xu W, Zhang W, Wang W, Liu T, Zhou X. LncRNA DCRF regulates cardiomyocyte autophagy by targeting miR-551b-5p in diabetic cardiomyopathy. Theranostics. 2019;9(15):4558\u201366.","journal-title":"Theranostics."},{"key":"231_CR110","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3389\/fcell.2020.00243","volume":"8","author":"Y Qi","year":"2020","unstructured":"Qi Y, Wu H, Mai C, Lin H, Shen J, Zhang X, et al. LncRNA-MIAT-Mediated miR-214-3p Silencing Is Responsible for IL-17 Production and Cardiac Fibrosis in Diabetic Cardiomyopathy. Front Cell Dev Biol. 2020;8:243.","journal-title":"Front Cell Dev Biol."},{"issue":"16","key":"231_CR111","doi-asserted-by":"publisher","first-page":"6809","DOI":"10.18632\/aging.204256","volume":"14","author":"S Wang","year":"2022","unstructured":"Wang S, Duan J, Liao J, Wang Y, Xiao X, Li L, et al. LncRNA H19 inhibits ER stress induced apoptosis and improves diabetic cardiomyopathy by regulating PI3K\/AKT\/mTOR axis. Aging (Albany NY). 2022;14(16):6809\u201328.","journal-title":"Aging (Albany NY)."},{"issue":"17","key":"231_CR112","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1111\/jcmm.17835","volume":"27","author":"T Wang","year":"2023","unstructured":"Wang T, Li N, Yuan L, Zhao M, Li G, Chen Y, Zhou H. MALAT1\/miR-185-5p mediated high glucose-induced oxidative stress, mitochondrial injury and cardiomyocyte apoptosis via the RhoA\/ROCK pathway. J Cell Mol Med. 2023;27(17):2495\u2013506.","journal-title":"J Cell Mol Med."},{"key":"231_CR113","doi-asserted-by":"crossref","unstructured":"Xu L, Chen W, Ma M, Chen A, Tang C, Zhang C, Cai L. Microarray profiling analysis identifies the mechanism of miR-200b-3p\/mRNA-CD36 affecting diabetic cardiomyopathy via peroxisome proliferator activated receptor-$$\\gamma$$ signaling pathway. J Cell Biochem. 2019;120(4):5193\u2013206.","DOI":"10.1002\/jcb.27795"}],"container-title":["Cardiovascular Diabetology \u2013 Endocrinology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40842-025-00231-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40842-025-00231-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40842-025-00231-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T22:07:24Z","timestamp":1757282844000},"score":1,"resource":{"primary":{"URL":"https:\/\/clindiabetesendo.biomedcentral.com\/articles\/10.1186\/s40842-025-00231-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":113,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["231"],"URL":"https:\/\/doi.org\/10.1186\/s40842-025-00231-x","relation":{},"ISSN":["3059-4057"],"issn-type":[{"value":"3059-4057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,8]]},"assertion":[{"value":"15 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}